American Equity Board Prefers Brookfield Deal to Athene-MassMutual Offer

News October 19, 2020 at 01:34 PM
Share & Print

Glass-walled office (Credit: Thinkstock)

American Equity Investment Life Holding Company has rejected an acquisition offer from Athene Holding Ltd. and Massachusetts Mutual Life Insurance Company.

The Athene-MassMutual offer is "is opportunistic, significantly undervalues the company, and is not in the best interests of American Equity and its shareholders and other stakeholders," according to a letter to Athene and MassMutual that was signed by John Matovina, who is American Equity's chairman, and by Anant Bhalla, the company's chief executive officer.

Resources

  • Links to documents related to American Equity's latest announcement, including a copy of the investment agreement, are available here.
  • An article about the Athene-MassMutual offer for American Equity is available here.

American Equity announced Sunday that its board has decided to enter into a strategic partnership with Brookfield Asset Management, rather than to accept the Athene-MassMutual acquisition offer.

The Offers

Athene and MassMutual have proposed a $3 billion cash offer for American Equity. The Athene-MassMutual deal would amount to a price of about $36 per American Equity share.

American Equity says Brookfield has offered to pay at least $37 per share in cash for a 19.9% stake in American Equity.

Brookfield would buy 9.9% of the company's stock as soon as antitrust regulators approved that purchase.

Brookfield then would buy another 10% stake, by June 30, 2021, after getting regulatory approvals and completing other arrangements. The price for the 10% stake could be higher than $37 per share if American Equity does well,, American Equity says.

Brookfield would also provide reinsurance for up to $10 billion n American Equity indexed annuity benefits obligations.

American Equity

American Equity is a publicly traded life insurer based in West Des Moines, Iowa. It's best known as an issuer of non-variable indexed annuities.

The company reported a $253 million net loss for the third quarter on $920 million in revenue. It recorded a $1.2 billion drop in the fair value of embedded derivatives.

The company also reported $100 million in operating income.

American Equity recently announced a reinsurance agreement with Värde Partners and Agam Capital Management. Värde, a Minneapolis-based money manager, said it will form a Bermuda-based reinsurance company that will reinsure $5 billion of American Equity non-variable indexed annuity obligations. The companies said Agam will help with risk management.

American Equity says the Brookfield deal will build on the Värde-Agam deal.

Brookfield Asset Management

Brookfield Asset Management is a Toronto-based financial services company that's managing about $500 billion in assets.

An arm of the company recently acquired control of Genworth MI Canada, a mortgage insurance provider in Canada, from Genworth Financial.

American Equity's Assessment of the Brookfield Deal

American Equity told investors during a conference call held Sunday that the Brookfield reinsurance arrangement would free about $300 million in American Equity capital, and start to generate stable, recurring, fee-like income.

The Brookfield deal also creates opportunities for American Equity and its shareholders to benefit from portfolio gains, and it will help American Equity shift toward tying earnings to its assets, rather than tying earnings to its equity, American Equity said.

Dear Athene and MassMutual…

Matovina and Bhalla wrote in their letter to Athene and MassMutual that American Equity's board "undertook an extensive, year-long review of strategic alternatives from the spring of 2018 through early June 2019.

The board talked to "strategic and other interested parties," Matovina and Bhalla wrote.

The board was willing to consider a range of options to enhance shareholder value, but the strategic review "did not result in any offers that were compelling or actionable," and the review process was "very disruptive to the company's employees and agents," Matovina and Bhalla wrote.

"Given our strong stand-alone prospects and our prior experience with this strategic review, our board does not believe that engaging on this unsolicited proposal is in our shareholders' and other stakeholders' best interests at this time," Matovina and Bhalla wrote.

Correction: An earlier version of this article described American Equity's concerns about the impact of the strategic review process incorrectly. Company leaders said they believe the review process itself was disruptive.

— Connect with ThinkAdvisor Life/Health on FacebookLinkedIn and Twitter.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Resource Center